The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 29, 2016
Filed:
Nov. 20, 2015
Applicant:
Ferring B.v., Hoofddorp, NL;
Inventors:
Assignee:
FERRING B.V., Hoofddorp, NL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 9/46 (2006.01); A61K 38/08 (2006.01); A61K 9/00 (2006.01); A61K 38/11 (2006.01); A61K 38/12 (2006.01); A61K 47/42 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0056 (2013.01); A61K 38/08 (2013.01); A61K 38/11 (2013.01); A61K 38/12 (2013.01); A61K 47/42 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2063 (2013.01); A61K 9/2095 (2013.01);
Abstract
Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary noctural enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way.